Susan Modesitt
Experienced in Lymphofollicular Hyperplasia

Dr. Susan Modesitt

Oncology
Emory health
Emory Clinic At 1365 Clifton Road
1365 Clifton Road Northeast, BldgA, 
Atlanta, GA 
Offers Telehealth
31 Years of Experience
Experienced in Lymphofollicular Hyperplasia
Emory health
Emory Clinic At 1365 Clifton Road
1365 Clifton Road Northeast, BldgA, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Susan Modesitt is an Oncologist in Atlanta, Georgia. Dr. Modesitt has been practicing medicine for over 31 years and is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Salpingo-Oophorectomy, and Hysterectomy.

Her clinical research consists of co-authoring 85 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Lymphofollicular Hyperplasia.

Graduate Institution
University Of Virginia School Of Medicine, 1995.0
Residency
University of North Carolina - Chapel Hill
Specialties
Oncology
Licenses
Obstetrics & Gynecology in VA
Board Certifications
American Board Of Obstetrics And Gynecology, 2005
Fellowships
MD Anderson Cancer Center
Hospital Affiliations
Emory University Hospital Midtown
Emory University Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Piedmont
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Emory Clinic at 1365 Clifton Road
1365 Clifton Road Northeast, BldgA, Atlanta, GA 30322
Call: 404-778-3401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Enrollment Status: Active_not_recruiting
Publish Date: January 14, 2026
Intervention Type: Drug, Procedure
Study Drugs: Carboplatin, Letrozole, Paclitaxel
Study Phase: Phase 3
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
Enrollment Status: Active_not_recruiting
Publish Date: December 30, 2025
Intervention Type: Other, Drug, Biological
Study Drugs: Bevacizumab, Carboplatin, Docetaxel, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 3
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Paclitaxel
Study Phase: Phase 3
A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Enrollment Status: Completed
Publish Date: October 20, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Enrollment Status: Unknown
Publish Date: September 30, 2021
Intervention Type: Other, Drug
Study Drugs: Carboplatin, Metformin hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
Phase II Evaluation of BIBF 1120 in the Treatment of Bevacizumab-Resistant, Persistent, or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Phase II Evaluation of BIBF 1120 in the Treatment of Bevacizumab-Resistant, Persistent, or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Enrollment Status: Completed
Publish Date: October 16, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

86 Total Publications

Silence is not an acceptable response to accusations of corruption: Expertise, integrity, and robust peer review processes safeguard ethical and data driven medical publications.
Silence is not an acceptable response to accusations of corruption: Expertise, integrity, and robust peer review processes safeguard ethical and data driven medical publications.
Journal: Gynecologic oncology reports
Published: July 04, 2025
View All 86 Publications
Similar Doctors
Distinguished in Lymphofollicular Hyperplasia
Dr. Louis C. Garrot
Hematology | Oncology
Distinguished in Lymphofollicular Hyperplasia
Dr. Louis C. Garrot
Hematology | Oncology

Georgia Cancer Specialists

790 Church Street Northeast, Suite 335, 
Marietta, GA 
 (15.7 miles away)
770-590-8311
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Louis Garrot is a Hematologist and an Oncologist in Marietta, Georgia. Dr. Garrot is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Lymphofollicular Hyperplasia, Familial Prostate Cancer, and Familial Pancreatic Cancer. Dr. Garrot is currently accepting new patients.

Jeffrey A. Thomas
Advanced in Lymphofollicular Hyperplasia
Dr. Jeffrey A. Thomas
Oncology | Hematology
Advanced in Lymphofollicular Hyperplasia
Dr. Jeffrey A. Thomas
Oncology | Hematology

University Cancer And Blood Center

3320 Old Jefferson Road, Building 700, 
Athens, GA 
 (53.5 miles away)
706-353-2990
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Thomas is a Hematologist and an Oncologist in Athens, Georgia. Dr. Thomas is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Midline Lethal Granuloma, Iron Deficiency Anemia, Essential Thrombocythemia, and Breast Cancer. Dr. Thomas is currently accepting new patients.

Jay M. Rhee
Advanced in Lymphofollicular Hyperplasia
Dr. Jay M. Rhee
Oncology | Hematology
Advanced in Lymphofollicular Hyperplasia
Dr. Jay M. Rhee
Oncology | Hematology

Piedmont Cancer Institute, PC

1800 Howell Mill Road Northwest, Suite 800, 
Atlanta, GA 
 (7.3 miles away)
404-350-9853
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jay Rhee is a Hematologist and an Oncologist in Atlanta, Georgia. Dr. Rhee is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Pleuropulmonary Blastoma, Thrombocytopenia, Acute Mountain Sickness, and Childhood Iron Deficiency Anemia. Dr. Rhee is currently accepting new patients.

VIEW MORE LYMPHOFOLLICULAR HYPERPLASIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Modesitt's expertise for a condition
ConditionClose
  • Elite
  • Endometrial Cancer
    Dr. Modesitt is
    Elite
    . Learn about Endometrial Cancer.
    See more Endometrial Cancer experts
  • Distinguished
  • Endometrial Stromal Sarcoma
    Dr. Modesitt is
    Distinguished
    . Learn about Endometrial Stromal Sarcoma.
    See more Endometrial Stromal Sarcoma experts
  • Malignant Mixed Mullerian Tumor
    Dr. Modesitt is
    Distinguished
    . Learn about Malignant Mixed Mullerian Tumor.
    See more Malignant Mixed Mullerian Tumor experts
  • Ovarian Cancer
    Dr. Modesitt is
    Distinguished
    . Learn about Ovarian Cancer.
    See more Ovarian Cancer experts
  • Advanced
  • Adult Soft Tissue Sarcoma
    Dr. Modesitt is
    Advanced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • BRCA Positive Breast Cancer
    Dr. Modesitt is
    Advanced
    . Learn about BRCA Positive Breast Cancer.
    See more BRCA Positive Breast Cancer experts
  • Cervical Cancer
    Dr. Modesitt is
    Advanced
    . Learn about Cervical Cancer.
    See more Cervical Cancer experts
  • Desmoplastic Small Round Cell Tumor
    Dr. Modesitt is
    Advanced
    . Learn about Desmoplastic Small Round Cell Tumor.
    See more Desmoplastic Small Round Cell Tumor experts
  • Li-Fraumeni Syndrome
    Dr. Modesitt is
    Advanced
    . Learn about Li-Fraumeni Syndrome.
    See more Li-Fraumeni Syndrome experts
  • Lump in the Abdomen
    Dr. Modesitt is
    Advanced
    . Learn about Lump in the Abdomen.
    See more Lump in the Abdomen experts
View All 16 Advanced Conditions
  • Experienced
  • Adenomyosis
    Dr. Modesitt is
    Experienced
    . Learn about Adenomyosis.
    See more Adenomyosis experts
  • Angiosarcoma
    Dr. Modesitt is
    Experienced
    . Learn about Angiosarcoma.
    See more Angiosarcoma experts
  • Breast Cancer
    Dr. Modesitt is
    Experienced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Cervical Dysplasia
    Dr. Modesitt is
    Experienced
    . Learn about Cervical Dysplasia.
    See more Cervical Dysplasia experts
  • Colorectal Cancer
    Dr. Modesitt is
    Experienced
    . Learn about Colorectal Cancer.
    See more Colorectal Cancer experts
  • DICER1 Syndrome
    Dr. Modesitt is
    Experienced
    . Learn about DICER1 Syndrome.
    See more DICER1 Syndrome experts
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.